
Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

FDA Approves First-in-Class Microbiota-Based Live Biotherapeutic for C. Difficile Infection

Adults with type 2 diabetes may benefit from eating more whole grains, fish, fiber, and omega-3 fatty acids in their diet, which could lower co-morbidities associated with death.

The FDA approved Azurity Pharmaceutical’s omeprazole and sodium bicarbonate for oral suspension to treat benign gastric ulcers and it is predicted to reach commercial markets by next year.

The first step to reducing recurrent C. difficile infections is prevention.

Most individuals can manage the discomfort of GERD with lifestyle changes and OTC medications.

A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.

Despite presenting in only 18% of cases, 16% of all COVID-19 patients only present with gastrointestinal symptoms.

The FDA granted breakthrough therapy designation to dupilumab in September 2020, for the treatment of patients age 12 years and older with eosinophilic esophagitis.

Educate patients about the appropriate and safe use of gastrointestinal products and direct them to seek further medical care when warranted.

Like diabetes, Inflammatory bowel disease may also be linked to a high-fructose diet.

Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.

Nizatidine Oral Solution is a prescription oral product used for the short-term treatment and maintenance therapy of ulcers and for the treatment of esophagitis and associated heartburn due to GERD.

Why was a patient prescribed something normally used for stomach problems to help her produce breastmilk?

Generic products featured in the April 2020 issue.

A survey conducted between March 30 to April 6 by InsightRx found that implementing the new vancomycin guidelines into the pharmacy community is as important as the coronavirus disease 2019 (COVID-19) in the healthcare system.

The clinical practice update incorporates emerging evidence and available guidance for patients with IBD.

What are you going to recommend for a customer who was unable to complete a previously recommended regimen?

In a series of studies, researchers described the identification of predictive tools and a new understanding of environmental factors that trigger inflammatory bowel disease.

The goal of therapy centers on improving quality of life, maintaining remission, and preventing hospitalization and surgery.

How can this patient better tolerate polyethylene glycol (PEG)-electrolyte lavage solution?

FIRST Omeprazole Kits offer a pre-measured option for pharmacists dispensing suspended Omeprazole.

Health care professionals can play an important role in managing patients with diarrhea by recommending OTC products for initial treatment.

Pharmacists are instrumental in guiding patients on the appropriate and safe use of products for gastrointestinal discomfort.

Just 22% of those who suffer seek help from a health care provider, newer agents show promise.

Diet and lifestyle changes are key components of treating gastroesophageal reflux disease.

The journal Cancer Chemotherapy and Pharmacology has published a review article that discusses repositioning of proton pump inhibitors (PPIs) in cancer treatment.